首页 > 最新文献

American Journal of Obstetrics & Gynecology Mfm最新文献

英文 中文
Barbed vs conventional sutures for cesarean uterine scar defects: a randomized clinical trial 剖宫产子宫瘢痕缺损的倒刺缝合与传统缝合:随机临床试验。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-16 DOI: 10.1016/j.ajogmf.2024.101431

Background

The role of barbed sutures in preventing myometrial defects and enhancing postpartum outcomes after cesarean section (C-section) is uncertain.

Objective

This study compared clinical and ultrasonographic outcomes of uterine scar defects after C-section with barbed and conventional smooth thread sutures.

Study Design

This was a multicenter, parallel-group, randomized, controlled clinical trial. Four obstetrics and gynecology departments across three Japanese healthcare regions were included. The participants were women requiring their first cesarean delivery between May 2020 and March 2023. Of the 1211 participants enrolled, 298 underwent C-section and 253 were followed up until July 2023. Participants with singleton pregnancies were randomly assigned (1:1 ratio) to receive either conventional or spiral thread sutures with a double-layer continuous suture. The study period comprised the time of consent to the 6- to 7-month examination. The primary endpoint was the rate of scar niches >2 mm evaluated using transvaginal ultrasonography at 6 to 7 months after surgery. Additional metrics included the total operative time, suture application time, operative blood loss, number of additional sutures required for hemostasis, maternal surgical complications, postoperative infections, surgeon's years of experience, and individual subscale scores.

Results

All data of the 220 participants (barbed suture group: 110; conventional suture group: 110) were available, thus enabling a full analysis set. A comparison of the barbed and conventional suture groups, respectively, revealed the following: niche length, 2.45±1.65 mm (range: 1.0–6.7) vs 3.79±1.84 mm (range: 1.0–11.0) (P<.001); niche depth, 1.78±1.07 mm (range: 1.0–5.7) vs 2.70±1.34 mm (range: 1.0–7.3) (P<.001); residual myometrial thickness (RMT), 8.46±1.74 mm (range: 4.8–13.0) vs 7.07±2.186 mm (range: 2.2–16.2) (P<.001); and niche width, 1.58±2.73 mm (range: 0.0–14.0) vs 2.88±2.36 mm (range: 0.0–11.0) (P<.001), respectively. The barbed suture group exhibited no defects and an RMT <3 mm. Furthermore, the barbed suture group had a lower rate of uterine niches (29.1%; n=32/110) than the conventional suture group (68.2%; n=75/110). Secondary outcomes showed no significant differences in operative times, maternal surgical complications, or postoperative complications.

Conclusion

Double-layer barbed sutures during cesarean delivery may prevent C-section scar defects and postoperative complications.

背景:倒钩缝合线在预防剖宫产术后子宫肌层缺损和提高产后效果方面的作用尚不确定:本研究比较了使用倒钩缝合线和传统平滑线缝合剖宫产术后子宫瘢痕缺损的临床和超声结果:这是一项多中心、平行组、随机对照临床试验。研究设计:这是一项多中心、平行组、随机对照临床试验,包括日本三个医疗保健地区的四个妇产科。参与者为 2020 年 5 月至 2023 年 3 月期间需要首次剖宫产的产妇。在1211名参与者中,298人接受了剖宫产手术,253人接受了随访,直至2023年7月。单胎妊娠的参与者被随机分配(1:1 比例)接受常规缝合或螺旋线双层连续缝合。研究期间包括同意接受治疗到 6 至 7 个月的检查。主要终点是术后6至7个月时通过经阴道超声波检查评估疤痕龛>2毫米的比率。其他指标包括手术总时间、缝合时间、手术失血量、止血所需的额外缝合次数、产妇手术并发症、术后感染、外科医生的经验年限以及个人分量表评分:220 名参与者(带刺缝合组:110 人;传统缝合组:110 人)的所有数据均已提供,因此可以进行全套分析。倒钩缝合组和传统缝合组的比较结果如下:缝龛长度,2.45±1.65 毫米(范围:1.0-6.7)对 3.79±1.84毫米(范围:1.0-11.0)(PC结论:剖宫产时双层倒刺缝合可预防剖宫产瘢痕缺损和术后并发症。
{"title":"Barbed vs conventional sutures for cesarean uterine scar defects: a randomized clinical trial","authors":"","doi":"10.1016/j.ajogmf.2024.101431","DOIUrl":"10.1016/j.ajogmf.2024.101431","url":null,"abstract":"<div><h3>Background</h3><p>The role of barbed sutures in preventing myometrial defects and enhancing postpartum outcomes after cesarean section (C-section) is uncertain.</p></div><div><h3>Objective</h3><p>This study compared clinical and ultrasonographic outcomes of uterine scar defects after C-section with barbed and conventional smooth thread sutures.</p></div><div><h3>Study Design</h3><p>This was a multicenter, parallel-group, randomized, controlled clinical trial. Four obstetrics and gynecology departments across three Japanese healthcare regions were included. The participants were women requiring their first cesarean delivery between May 2020 and March 2023. Of the 1211 participants enrolled, 298 underwent C-section and 253 were followed up until July 2023. Participants with singleton pregnancies were randomly assigned (1:1 ratio) to receive either conventional or spiral thread sutures with a double-layer continuous suture. The study period comprised the time of consent to the 6- to 7-month examination. The primary endpoint was the rate of scar niches &gt;2 mm evaluated using transvaginal ultrasonography at 6 to 7 months after surgery. Additional metrics included the total operative time, suture application time, operative blood loss, number of additional sutures required for hemostasis, maternal surgical complications, postoperative infections, surgeon's years of experience, and individual subscale scores.</p></div><div><h3>Results</h3><p>All data of the 220 participants (barbed suture group: 110; conventional suture group: 110) were available, thus enabling a full analysis set. A comparison of the barbed and conventional suture groups, respectively, revealed the following: niche length, 2.45±1.65 mm (range: 1.0–6.7) vs 3.79±1.84 mm (range: 1.0–11.0) (<em>P</em>&lt;.001); niche depth, 1.78±1.07 mm (range: 1.0–5.7) vs 2.70±1.34 mm (range: 1.0–7.3) (<em>P</em>&lt;.001); residual myometrial thickness (RMT), 8.46±1.74 mm (range: 4.8–13.0) vs 7.07±2.186 mm (range: 2.2–16.2) (<em>P</em>&lt;.001); and niche width, 1.58±2.73 mm (range: 0.0–14.0) vs 2.88±2.36 mm (range: 0.0–11.0) (<em>P</em>&lt;.001), respectively. The barbed suture group exhibited no defects and an RMT &lt;3 mm. Furthermore, the barbed suture group had a lower rate of uterine niches (29.1%; <em>n</em>=32/110) than the conventional suture group (68.2%; <em>n</em>=75/110). Secondary outcomes showed no significant differences in operative times, maternal surgical complications, or postoperative complications.</p></div><div><h3>Conclusion</h3><p>Double-layer barbed sutures during cesarean delivery may prevent C-section scar defects and postoperative complications.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589933324001575/pdfft?md5=d0eaf442630794a1641e58d6fe4d5637&pid=1-s2.0-S2589933324001575-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing a nurse-initiated protocol to improve response to perinatal severe hypertension 实施由护士发起的方案,改善围产期严重高血压的应对措施。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-09 DOI: 10.1016/j.ajogmf.2024.101424
{"title":"Implementing a nurse-initiated protocol to improve response to perinatal severe hypertension","authors":"","doi":"10.1016/j.ajogmf.2024.101424","DOIUrl":"10.1016/j.ajogmf.2024.101424","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of influenza vaccination during pregnancy 孕期接种流感疫苗的时机。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-05 DOI: 10.1016/j.ajogmf.2024.101427
{"title":"Timing of influenza vaccination during pregnancy","authors":"","doi":"10.1016/j.ajogmf.2024.101427","DOIUrl":"10.1016/j.ajogmf.2024.101427","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perinatal mental healthcare utilization among patients with placenta accreta spectrum 胎盘早剥患者利用围产期精神保健的情况。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101405
Sarah R. Casey BS, BSA, Alison N. Goulding MD, MSCR, Christina C. Reed MSN, Amir A. Shamshirsaz MD, Hennie A. Lombaard MD, Michael A. Belfort MBBCh, MD, PhD, Lisa M. Noll PhD, Karin A. Fox MD, MEd
{"title":"Perinatal mental healthcare utilization among patients with placenta accreta spectrum","authors":"Sarah R. Casey BS, BSA,&nbsp;Alison N. Goulding MD, MSCR,&nbsp;Christina C. Reed MSN,&nbsp;Amir A. Shamshirsaz MD,&nbsp;Hennie A. Lombaard MD,&nbsp;Michael A. Belfort MBBCh, MD, PhD,&nbsp;Lisa M. Noll PhD,&nbsp;Karin A. Fox MD, MEd","doi":"10.1016/j.ajogmf.2024.101405","DOIUrl":"10.1016/j.ajogmf.2024.101405","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141311886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive modeling of postpartum blood pressure spikes 产后血压峰值的预测模型。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101301
Jinxin Tao PhD , Scott Infusino MD , Yonatan Mintz PhD , Kara K. Hoppe DO, MS

BACKGROUND

Hypertensive disorders of pregnancy are one of the leading causes of maternal morbidity and mortality worldwide. Management of these conditions can pose many clinical dilemmas and can be particularly challenging during the immediate postpartum period. Models for predicting and managing postpartum hypertension are necessary to help address this clinical challenge.

OBJECTIVE

This study aimed to evaluate predictive models of blood pressure spikes in the postpartum period and to investigate clinical management strategies to optimize care.

STUDY DESIGN

This was a retrospective cohort study of postpartum women who participated in remote blood pressure monitoring. A postpartum blood pressure spike was defined as a blood pressure measurement of ≥140/90 mm Hg while on an antihypertensive medication and a blood pressure measurement of ≥150/100 mm Hg if not on an antihypertensive medication. We identified 3 risk level patient clusters (low, medium, and high) when predicting patient risk for a blood pressure spike on postpartum days 3 to 7. The variables used in defining these clusters were peak systolic blood pressure before discharge, body mass index, patient systolic blood pressure per trimester, heart rate, gestational age, maternal age, chronic hypertension, and gestational hypertension. For each risk cluster, we focused on 2 treatments, namely (1) postpartum length of stay (<3 days or ≥3 days) and (2) discharge with or without blood pressure medications. We evaluated the effectiveness of the treatments in different subgroups of patients by estimating the conditional average treatment effect values in each cluster using a causal forest. Moreover, for all patients, we considered discharge with medication policies depending on different discharge blood pressure thresholds. We used a doubly robust policy evaluation method to compare the effectiveness of the policies.

RESULTS

A total of 413 patients were included, and among those, 267 (64.6%) had a postpartum blood pressure spike. The treatments for patients at medium and high risk were considered beneficial. The 95% confidence intervals for constant marginal average treatment effect for antihypertensive use at discharge were −3.482 to 4.840 and − 5.539 to 4.315, respectively; and for a longer stay they were −5.544 to 3.866 and −7.200 to 4.302, respectively. For patients at low risk, the treatments were not critical in preventing a blood pressure spike with 95% confidence intervals for constant marginal average treatment effect of 1.074 to 15.784 and −2.913 to 9.021 for the different treatments. We considered the option to discharge patients with antihypertensive use at different blood pressure thresholds, namely (1) ≥130 mm Hg and/or ≥80 mm Hg, (2) ≥140 mm Hg and/or ≥90 mm Hg, (3) ≥150 mm Hg and/or ≥ 100 mm Hg, or (4) ≥160 mm Hg and/or ≥ 110 mm Hg. We found that policy (2) was the best option with P

背景:妊娠期高血压疾病(HDP)是导致全球孕产妇发病和死亡的主要原因之一。这些疾病的管理会带来许多临床难题,尤其是在产后期间。有必要建立预测和管理产后高血压的模型,以帮助应对这一临床挑战:评估产后血压(BP)峰值的预测模型,并研究优化护理的临床管理策略:方法:对参与远程血压监测的产后妇女进行回顾性队列研究。如果正在服用降压药,产后血压飙升的定义为血压≥140/90;如果未服用降压药,产后血压飙升的定义为血压≥150/100。在预测 PP 第 3-7 天患者血压骤升的风险时,我们确定了 3 个风险水平患者群组(低、中、高)。用于定义这些群组的变量包括出院前收缩压(SBP)峰值、体重指数(BMI)、患者每胎收缩压、心率、胎龄、孕产妇年龄、慢性高血压和妊娠高血压。对于每个风险群组,我们重点关注两种处理方法:1) PP住院时间<或>/=3天;2)出院时服用或不服用降压药。我们利用因果森林分别估算了每个群组的条件平均治疗效果(CATE)值,从而评估了治疗方法对不同亚群患者的有效性。此外,对于所有患者,我们还根据不同的出院血压阈值考虑了出院用药政策。我们采用了双重稳健政策评估方法来比较政策的有效性:结果:共纳入 413 名患者,其中 267 人(64.6%)出现 PP 血压峰值。中、高风险患者的治疗被认为是有益的,出院时使用降压药的恒定边际平均治疗效果的 95% 置信区间分别为(-3.482, 4.840)和(-5.539, 4.315);延长住院时间的恒定边际平均治疗效果的 95% 置信区间分别为(-5.544, 3.866)和(-7.200, 4.302)。对于低风险患者,治疗方法对防止血压骤升并不重要,其恒定边际平均治疗效果的 95% 置信区间分别为(1.074, 15.784)和(-2.913, 9.021)。我们考虑了在不同血压阈值(a)≥ 130 mmHg 和/或≥ 80、(b)≥ 140 mmHg 和/或≥ 90、(c)≥ 150 mmHg 和/或≥ 100 或(d)≥ 160 mmHg 和/或≥ 110 时使用降压药的出院方案,我们发现在 PConclusions 中,政策(b)是最佳方案:我们发现了预防门诊血压骤升的 3 种可能策略:1)中高危患者应考虑延长 PP 的住院时间或参与每日家庭监测;2)中高危患者出院时应处方降压药;3)如果患者出院时血压≥140/90,应处方降压治疗。
{"title":"Predictive modeling of postpartum blood pressure spikes","authors":"Jinxin Tao PhD ,&nbsp;Scott Infusino MD ,&nbsp;Yonatan Mintz PhD ,&nbsp;Kara K. Hoppe DO, MS","doi":"10.1016/j.ajogmf.2024.101301","DOIUrl":"10.1016/j.ajogmf.2024.101301","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Hypertensive disorders of pregnancy are one of the leading causes of maternal morbidity and mortality worldwide. Management of these conditions can pose many clinical dilemmas and can be particularly challenging during the immediate postpartum period. Models for predicting and managing postpartum hypertension are necessary to help address this clinical challenge.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to evaluate predictive models of blood pressure spikes in the postpartum period and to investigate clinical management strategies to optimize care.</p></div><div><h3>STUDY DESIGN</h3><p>This was a retrospective cohort study of postpartum women who participated in remote blood pressure monitoring. A postpartum blood pressure spike was defined as a blood pressure measurement of ≥140/90 mm Hg while on an antihypertensive medication and a blood pressure measurement of ≥150/100 mm Hg if not on an antihypertensive medication. We identified 3 risk level patient clusters (low, medium, and high) when predicting patient risk for a blood pressure spike on postpartum days 3 to 7. The variables used in defining these clusters were peak systolic blood pressure before discharge, body mass index, patient systolic blood pressure per trimester, heart rate, gestational age, maternal age, chronic hypertension, and gestational hypertension. For each risk cluster, we focused on 2 treatments, namely (1) postpartum length of stay (&lt;3 days or ≥3 days) and (2) discharge with or without blood pressure medications. We evaluated the effectiveness of the treatments in different subgroups of patients by estimating the conditional average treatment effect values in each cluster using a causal forest. Moreover, for all patients, we considered discharge with medication policies depending on different discharge blood pressure thresholds. We used a doubly robust policy evaluation method to compare the effectiveness of the policies.</p></div><div><h3>RESULTS</h3><p>A total of 413 patients were included, and among those, 267 (64.6%) had a postpartum blood pressure spike. The treatments for patients at medium and high risk were considered beneficial. The 95% confidence intervals for constant marginal average treatment effect for antihypertensive use at discharge were −3.482 to 4.840 and − 5.539 to 4.315, respectively; and for a longer stay they were −5.544 to 3.866 and −7.200 to 4.302, respectively. For patients at low risk, the treatments were not critical in preventing a blood pressure spike with 95% confidence intervals for constant marginal average treatment effect of 1.074 to 15.784 and −2.913 to 9.021 for the different treatments. We considered the option to discharge patients with antihypertensive use at different blood pressure thresholds, namely (1) ≥130 mm Hg and/or ≥80 mm Hg, (2) ≥140 mm Hg and/or ≥90 mm Hg, (3) ≥150 mm Hg and/or ≥ 100 mm Hg, or (4) ≥160 mm Hg and/or ≥ 110 mm Hg. We found that policy (2) was the best option with <em>P","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139567486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial 导管球囊插入引产前使用帕帕维林:随机对照试验。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101388
Raneen Abu Shqara MD , Yara Nakhleh Francis MD , Gabriela Goldinfeld MD , Yousef Haddad MD , Inshirah Sgayer MD , Miri Lavinsky BA , Lior Lowenstein MD , Maya Frank Wolf MD

BACKGROUND

Catheter balloon insertion is a common method for cervical ripening and labor induction. Papaverine and its derivatives are musculotropic antispasmodic drugs that directly induce smooth muscle relaxation. Used during childbirth, these drugs have been suggested to shorten the duration of labor.

OBJECTIVE

This study aimed to evaluate the effect of administering papaverine before catheter balloon insertion on changes in Bishop scores and on the labor induction–to–delivery interval.

STUDY DESIGN

This randomized, double-blinded, placebo-controlled trial was conducted in a single tertiary university-affiliated hospital. Participants were admitted at term for labor induction with an initial Bishop score of ≤6. Participants were randomized to receive 80 mg intravenous papaverine or 0.9% normal saline solution within 30 minutes of Foley catheter balloon insertion. The co-primary outcomes were the difference in Bishop score from before catheter balloon insertion to after removal and the labor induction–to–delivery interval. The secondary outcomes included maternal pain and satisfaction scores, delivery within 24 hours, and neonatal outcomes. Both intention-to-treat and per-protocol analyses were performed.

RESULTS

Overall, 110 women were enrolled. In the intention-to-treat analysis, the median difference in Bishop score was greater in the papaverine group than in the placebo group (5 [interquartile range, 1-11] vs 4 [interquartile range, 0-7], respectively; P=.025), and the median catheter balloon insertion–to–delivery interval was shorter in the papaverine group than in the placebo group (21 hours [interquartile range, 6–95] vs 26 hours [interquartile range, 3–108], respectively; P=.031). A higher proportion of women delivered within 24-hours in the papaverine group than in the placebo group (65.5% vs 41.8%, respectively; P=.012). Pain and satisfaction scores, delivery, and neonatal outcomes were similar between the groups. Similar results were found in the per-protocol analysis.

CONCLUSION

Papaverine administration before Foley catheter balloon insertion for cervical ripening resulted in improved Bishop scores and shorter catheter balloon insertion–to–delivery intervals.

背景介绍导管球囊植入是一种宫颈成熟的引产方法。木蝴蝶碱及其衍生物是一种肌肉解痉药,可直接诱导平滑肌松弛。在分娩过程中使用这些药物可缩短产程:我们的目的是评估在插入导尿管球囊前使用帕帕维林对 Bishop 评分变化和引产至分娩间隔时间的影响:这项随机双盲安慰剂对照试验在一家大学附属三级医院进行。参试者在临产时入院接受引产,初始毕晓普评分≤6。在插入 Foley 导管球囊后 30 分钟内,参与者被随机分配接受 80 毫克或 0.9% 生理盐水静脉注射。共同主要结果是插入导管气囊前与拔出导管气囊后的 Bishop 评分差异,以及从引产到分娩的时间间隔。次要结果包括产妇疼痛和满意度评分、24 小时内分娩情况和新生儿结局。结果:结果:共有 110 名产妇报名参加。在意向治疗分析中,与安慰剂组(55 人)相比,木瓜碱组(55 人)的 Bishop 评分中位数(范围)差异更大:7 分(范围,4-11 分)对 6 分(1-11 分),P=0.023;导管插入到分娩的中位数范围间隔更短:21(6-95)小时对 26(3-108)小时,P=0.031。与安慰剂组相比,木瓜碱组产妇在24小时内分娩的比例更高:65.5%对41.8%,P=0.012。两组的疼痛和满意度评分、分娩和新生儿结局相似。在按方案分析中也发现了类似的结果:结论:为宫颈成熟术插入 Foley 导管前使用帕帕维林可提高 Bishop 评分,缩短导管到分娩的时间间隔。
{"title":"Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial","authors":"Raneen Abu Shqara MD ,&nbsp;Yara Nakhleh Francis MD ,&nbsp;Gabriela Goldinfeld MD ,&nbsp;Yousef Haddad MD ,&nbsp;Inshirah Sgayer MD ,&nbsp;Miri Lavinsky BA ,&nbsp;Lior Lowenstein MD ,&nbsp;Maya Frank Wolf MD","doi":"10.1016/j.ajogmf.2024.101388","DOIUrl":"10.1016/j.ajogmf.2024.101388","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Catheter balloon insertion is a common method for cervical ripening and labor induction. Papaverine and its derivatives are musculotropic antispasmodic drugs that directly induce smooth muscle relaxation. Used during childbirth, these drugs have been suggested to shorten the duration of labor.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to evaluate the effect of administering papaverine before catheter balloon insertion on changes in Bishop scores and on the labor induction–to–delivery interval.</p></div><div><h3>STUDY DESIGN</h3><p>This randomized, double-blinded, placebo-controlled trial was conducted in a single tertiary university-affiliated hospital. Participants were admitted at term for labor induction with an initial Bishop score of ≤6. Participants were randomized to receive 80 mg intravenous papaverine or 0.9% normal saline solution within 30 minutes of Foley catheter balloon insertion. The co-primary outcomes were the difference in Bishop score from before catheter balloon insertion to after removal and the labor induction–to–delivery interval. The secondary outcomes included maternal pain and satisfaction scores, delivery within 24 hours, and neonatal outcomes. Both intention-to-treat and per-protocol analyses were performed.</p></div><div><h3>RESULTS</h3><p>Overall, 110 women were enrolled. In the intention-to-treat analysis, the median difference in Bishop score was greater in the papaverine group than in the placebo group (5 [interquartile range, 1-11] vs 4 [interquartile range, 0-7], respectively; <em>P</em>=.025), and the median catheter balloon insertion–to–delivery interval was shorter in the papaverine group than in the placebo group (21 hours [interquartile range, 6–95] vs 26 hours [interquartile range, 3–108], respectively; <em>P</em>=.031). A higher proportion of women delivered within 24-hours in the papaverine group than in the placebo group (65.5% vs 41.8%, respectively; <em>P</em>=.012). Pain and satisfaction scores, delivery, and neonatal outcomes were similar between the groups. Similar results were found in the per-protocol analysis.</p></div><div><h3>CONCLUSION</h3><p>Papaverine administration before Foley catheter balloon insertion for cervical ripening resulted in improved Bishop scores and shorter catheter balloon insertion–to–delivery intervals.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChatGPT in maternal-fetal medicine practice: comment 母胎医学实践中的 ChatGPT:评论。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101360
Hinpetch Daungsupawong PhD , Viroj Wiwanitkit MD
{"title":"ChatGPT in maternal-fetal medicine practice: comment","authors":"Hinpetch Daungsupawong PhD ,&nbsp;Viroj Wiwanitkit MD","doi":"10.1016/j.ajogmf.2024.101360","DOIUrl":"10.1016/j.ajogmf.2024.101360","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardio-obstetrics de novo: a state-level, evidence-based approach for addressing maternal mortality and severe maternal morbidity in Georgia 从头开始的心血管产科:在佐治亚州解决孕产妇死亡和严重孕产妇发病问题的州级循证方法。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101334
Chadburn B. Ray MD , James E. Maher MD , Gyanendra Sharma MD , Padmashree C. Woodham MD , Lawrence D. Devoe MD

Georgia has a higher rate of severe maternal morbidity and mortality when compared with the rest of the United States. Evidence gained from the Georgia Maternal Mortality Review Committee identified areas of focus for high-yield clinical initiatives for improvement in maternal health outcomes. Cardiovascular disease, including cardiomyopathy, coronary conditions, and preeclampsia with or without eclampsia, is the most common cause of pregnancy-related death in non-Hispanic Black women in Georgia. The development of a cardio-obstetrics program is an initiative to advance health equity by decreasing cardiovascular morbidity and mortality. This report describes the following: (1) state-level advocacy for improving maternal health outcomes with funding gained through the legislative process and partnership with a governmental agency; (2) cardio-obstetrics program development based on evidence gained from the maternal mortality review process; and (3) implementation of a cardio-obstetrics service, beginning with a focused approach for capacity building and understanding barriers to care.

与美国其他地区相比,佐治亚州的孕产妇发病率和死亡率都很高1-6。佐治亚州孕产妇死亡率审查委员会(Georgia Maternal Mortality Review Committee)获得的证据确定了改善孕产妇健康状况的高收益临床措施的重点领域2,7,8。心血管疾病,包括心肌病、冠心病和先兆子痫/子痫,是佐治亚州非西班牙裔黑人妇女最常见的妊娠相关死亡原因9-11。制定心血管产科计划是一项通过降低心血管发病率和死亡率来促进健康公平的举措。本报告介绍了以下内容:(1) 在州一级倡导改善孕产妇健康结果,通过立法程序和与政府机构合作获得资金;(2) 根据孕产妇死亡率审查过程中获得的证据制定心血管产科计划;以及 (3) 实施心血管产科服务,从能力建设和了解护理障碍的重点方法开始。
{"title":"Cardio-obstetrics de novo: a state-level, evidence-based approach for addressing maternal mortality and severe maternal morbidity in Georgia","authors":"Chadburn B. Ray MD ,&nbsp;James E. Maher MD ,&nbsp;Gyanendra Sharma MD ,&nbsp;Padmashree C. Woodham MD ,&nbsp;Lawrence D. Devoe MD","doi":"10.1016/j.ajogmf.2024.101334","DOIUrl":"10.1016/j.ajogmf.2024.101334","url":null,"abstract":"<div><p>Georgia has a higher rate of severe maternal morbidity and mortality when compared with the rest of the United States. Evidence gained from the Georgia Maternal Mortality Review Committee identified areas of focus for high-yield clinical initiatives for improvement in maternal health outcomes. Cardiovascular disease, including cardiomyopathy, coronary conditions, and preeclampsia with or without eclampsia, is the most common cause of pregnancy-related death in non-Hispanic Black women in Georgia. The development of a cardio-obstetrics program is an initiative to advance health equity by decreasing cardiovascular morbidity and mortality. This report describes the following: (1) state-level advocacy for improving maternal health outcomes with funding gained through the legislative process and partnership with a governmental agency; (2) cardio-obstetrics program development based on evidence gained from the maternal mortality review process; and (3) implementation of a cardio-obstetrics service, beginning with a focused approach for capacity building and understanding barriers to care.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘Diagnosis of Fetal Growth Restriction in a Cohort of Small-for-Gestational Age Neonates at Term: Neonatal and Maternal Outcomes’ American Journal of Obstetrics & Gynecology MFM/ Volume 4, Issue 5, September 2022/100672 胎儿生长受限的诊断:美国妇产科杂志》MFM/第 4 卷第 5 期,2022 年 9 月/100672。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101419
Beth L. Pineles MD, PhD, Hector Mendez-Figueroa MD, Suneet P. Chauhan MD, Hon DSc
{"title":"Corrigendum to ‘Diagnosis of Fetal Growth Restriction in a Cohort of Small-for-Gestational Age Neonates at Term: Neonatal and Maternal Outcomes’ American Journal of Obstetrics & Gynecology MFM/ Volume 4, Issue 5, September 2022/100672","authors":"Beth L. Pineles MD, PhD,&nbsp;Hector Mendez-Figueroa MD,&nbsp;Suneet P. Chauhan MD, Hon DSc","doi":"10.1016/j.ajogmf.2024.101419","DOIUrl":"10.1016/j.ajogmf.2024.101419","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589933324001459/pdfft?md5=04b01d97f446675f98039d85767ae448&pid=1-s2.0-S2589933324001459-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding “Risk factors for placenta accreta spectrum disorder among patients with placenta previa and prior cesarean delivery” 致编辑的信,内容涉及 "前置胎盘且曾进行剖宫产的患者发生胎盘早剥谱系障碍的风险因素"。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.ajogmf.2024.101380
Eileen Wang-Koehler MD, Beth L. Pineles MD, PhD
{"title":"Letter to the editor regarding “Risk factors for placenta accreta spectrum disorder among patients with placenta previa and prior cesarean delivery”","authors":"Eileen Wang-Koehler MD,&nbsp;Beth L. Pineles MD, PhD","doi":"10.1016/j.ajogmf.2024.101380","DOIUrl":"10.1016/j.ajogmf.2024.101380","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Obstetrics & Gynecology Mfm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1